Alkermes (ALKS) Stock Forecast & Price Target
$7.63B
Market Cap
109.63
P/E
83.47
Forward P/E
38
Score
ALKS price $45.51 +0.26 +0.56%
Stocklytics score rationale: value 31, quality 39, growth 44.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 745694000 | 903374000 | 1094274000 | 1170947000 | 1038756000 | 1173751000 | 1111795000 | 1663405000 | 1557632000 | 1475899000 |
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of…
ALKS fair value $44.36. Price $45.51. Price is about fair value.
Above fair value, around its usual premium.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 413.09M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 167.76M. Net debt -1.05B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | -0.08 | — | 463.59M |
| 2026-07-28 | 0.70 | -0.03 | 496.01M | 457.38M |
| 2026-05-05 | -0.40 | -0.57 | 392.91M | 363.06M |
| 2026-02-25 | 0.34 | 0.43 | 384.55M | 378.94M |
| 2025-10-28 | 0.49 | 0.37 | 394.19M | 356.89M |
| 2025-07-29 | 0.52 | 0.41 | 390.66M | 354.51M |
| 2025-05-01 | 0.13 | 0.25 | 306.51M | 302.91M |
| 2025-02-12 | 1.04 | 0.81 | 429.99M | 379.42M |
| 2024-10-24 | 0.72 | 0.74 | 378.14M | 381.36M |
| 2024-07-24 | 0.70 | 0.70 | 399.13M | 382.82M |
| 2024-05-01 | 0.44 | 0.59 | 350.37M | 393.35M |
| 2024-02-15 | 0.22 | 0.46 | 377.48M | 362.22M |
| 2023-10-25 | 0.64 | 0.44 | 380.94M | 362.15M |
| 2023-07-26 | 0.55 | 0.48 | 617.40M | 363.87M |
| 2023-04-26 | 0.01 | 0.00 | 287.60M | 580.89M |
| 2023-02-16 | 0.14 | 0.05 | 304.67M | 278.69M |
| 2022-11-02 | 0.02 | 0.03 | 252.36M | 271.41M |
| 2022-07-27 | 0.06 | 0.01 | 276.22M | 268.97M |
| 2022-04-27 | 0.12 | 0.01 | 278.55M | 256.02M |
| 2022-02-16 | 0.23 | 0.13 | 324.46M | 306.55M |
| 2021-10-27 | 0.14 | 0.08 | 294.14M | 242.67M |
| 2021-07-28 | 0.30 | 0.12 | 303.72M | 299.70M |
| 2021-04-28 | 0.11 | -0.05 | 251.43M | 233.87M |
| 2021-02-11 | 0.10 | 0.07 | 280.00M | 268.02M |
| 2020-10-29 | 0.26 | 0.00 | 265.01M | — |
| 2020-07-29 | 0.06 | 0.01 | 247.53M | 41.25M |
| 2020-04-29 | 0.01 | -0.08 | 246.22M | 1.48B |
| 2020-02-13 | 0.83 | 0.66 | 412.73M | 323.22M |
| 2019-10-23 | -0.04 | -0.20 | 255.24M | 1.34B |
| 2019-07-25 | 0.09 | -0.10 | 279.87M | 373.16M |
| 2019-04-25 | -0.17 | -0.19 | 223.10M | 275.60M |
| 2019-02-14 | 0.34 | -0.06 | 315.76M | 37.15M |
| 2018-10-23 | 0.07 | -0.06 | 248.72M | 248.72M |
| 2018-07-26 | 0.29 | 0.10 | 304.64M | 272.61M |
| 2018-04-26 | -0.09 | -0.08 | 225.15M | 175.16M |
| 2018-02-14 | 0.31 | 0.21 | 275.37M | 204.33M |
| 2017-10-26 | 0.03 | 0.01 | 217.38M | 72.47M |
| 2017-07-27 | 0.01 | 0.00 | 218.84M | 218.80M |
| 2017-04-27 | -0.18 | -0.08 | 191.78M | 95.90M |
| 2017-02-15 | 0.15 | 0.04 | 213.51M | 427.00M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-08 | Reed Joshua | Sell | 9.16K | — | — |
| 2026-10-08 | Reed Joshua | Buy | 9.16K | — | — |
| 2026-10-08 | Reed Joshua | Sell | 4.07K | $40.11 | 163.21K |
| 2026-10-07 | Whitaker Anne Clem | Buy | 18.00K | $41.45 | 745.93K |
| 2026-10-07 | Whitaker Anne Clem | Buy | 7.24K | — | — |
| 2026-10-02 | Gaffin David Joseph | Sell | 2.03K | $41.03 | 83.46K |
| 2026-09-14 | Whitaker Anne Clem | Other | 0 | — | — |
| 2026-09-03 | Gaffin David Joseph | Sell | 2.03K | $48.01 | 97.65K |
| 2026-09-01 | Hopkinson Craig C. | Buy | 5.00K | $24.59 | 122.95K |
| 2026-09-01 | Hopkinson Craig C. | Sell | 9.00K | $46.99 | 422.87K |
| 2026-09-01 | Hopkinson Craig C. | Sell | 5.00K | $24.59 | 122.95K |
| 2026-08-17 | Nichols Christian Todd | Sell | 6.91K | $49.19 | 339.97K |
| 2026-08-17 | Nichols Christian Todd | Sell | 664 | $49.65 | 32.97K |
| 2026-08-05 | Jackson Blair Curtis | Buy | 124.31K | $49.61 | 6.17M |
| 2026-08-05 | Jackson Blair Curtis | Buy | 93.23K | $49.61 | 4.63M |
| 2026-08-03 | snyderman nancy lynn MD | Buy | 16.52K | $46.72 | 772.00K |
| 2026-08-03 | snyderman nancy lynn MD | Buy | 27.95K | $46.72 | 1.31M |
| 2026-08-03 | snyderman nancy lynn MD | Sell | 44.47K | $50.35 | 2.24M |
| 2026-08-03 | snyderman nancy lynn MD | Sell | 16.52K | $46.72 | 772.00K |
| 2026-08-03 | Hopkinson Craig C. | Buy | 4.90K | $24.59 | 120.39K |
| 2026-08-03 | Hopkinson Craig C. | Buy | 104 | $19.34 | 2.01K |
| 2026-08-03 | Hopkinson Craig C. | Sell | 9.00K | $48.58 | 437.22K |
| 2026-08-03 | Hopkinson Craig C. | Sell | 4.90K | $24.59 | 120.39K |
| 2026-08-03 | Hopkinson Craig C. | Sell | 104 | $19.34 | 2.01K |
| 2026-08-03 | Gaffin David Joseph | Sell | 2.03K | $48.58 | 98.81K |
| 2026-07-06 | Gaffin David Joseph | Sell | 2.03K | $54.03 | 109.90K |
| 2026-07-01 | Hopkinson Craig C. | Buy | 5.00K | $19.34 | 96.70K |
| 2026-07-01 | Hopkinson Craig C. | Sell | 8.30K | $51.46 | 427.13K |
| 2026-07-01 | Hopkinson Craig C. | Sell | 700 | $52.13 | 36.49K |
| 2026-07-01 | Hopkinson Craig C. | Sell | 5.00K | $19.34 | 96.70K |
| 2026-06-12 | Wright Christopher I | Sell | 2.00K | $45.10 | 90.20K |
| 2026-06-04 | Gaffin David Joseph | Sell | 2.03K | $43.05 | 87.56K |
| 2026-06-01 | Hopkinson Craig C. | Buy | 5.00K | $19.34 | 96.70K |
| 2026-06-01 | Hopkinson Craig C. | Sell | 9.00K | $41.67 | 375.04K |
| 2026-06-01 | Hopkinson Craig C. | Sell | 5.00K | $19.34 | 96.70K |
| 2026-05-29 | Parisi Samuel Joseph | Buy | 12.82K | $19.34 | 248.04K |
| 2026-05-29 | Parisi Samuel Joseph | Sell | 12.82K | $19.34 | 248.04K |
| 2026-05-29 | Parisi Samuel Joseph | Buy | 3.39K | $20.03 | 67.94K |
| 2026-05-29 | Parisi Samuel Joseph | Sell | 16.22K | $42.36 | 687.01K |
| 2026-05-29 | Parisi Samuel Joseph | Sell | 3.39K | $20.03 | 67.94K |
| 2026-05-21 | Wright Christopher I | Buy | 6.14K | — | — |
| 2026-05-21 | Wright Christopher I | Sell | 1.48K | $36.95 | 54.50K |
| 2026-05-21 | Wright Christopher I | Sell | 6.14K | — | — |
| 2026-05-21 | Wilson Frank Anders | Buy | 6.14K | — | — |
| 2026-05-21 | Wilson Frank Anders | Sell | 1.48K | $36.95 | 54.50K |
| 2026-05-21 | Wilson Frank Anders | Sell | 6.14K | — | — |
| 2026-05-21 | snyderman nancy lynn MD | Buy | 6.14K | — | — |
| 2026-05-21 | snyderman nancy lynn MD | Sell | 1.48K | $36.95 | 54.50K |
| 2026-05-21 | snyderman nancy lynn MD | Sell | 6.14K | — | — |
| 2026-05-21 | MCKEON BRIAN P | Buy | 6.14K | — | — |
| 2026-05-21 | MCKEON BRIAN P | Sell | 1.48K | $36.95 | 54.50K |
| 2026-05-21 | MCKEON BRIAN P | Sell | 6.14K | — | — |
| 2026-05-21 | Lurker Nancy | Buy | 6.14K | — | — |
| 2026-05-21 | Lurker Nancy | Sell | 1.48K | $36.95 | 54.50K |
| 2026-05-21 | Lurker Nancy | Sell | 6.14K | — | — |
| 2026-05-21 | LAURENCIN CATO T | Buy | 6.14K | — | — |
| 2026-05-21 | LAURENCIN CATO T | Sell | 1.48K | $36.95 | 54.50K |
| 2026-05-21 | LAURENCIN CATO T | Sell | 6.14K | — | — |
| 2026-05-21 | GAYNOR RICHARD | Buy | 6.14K | — | — |
| 2026-05-21 | GAYNOR RICHARD | Sell | 1.48K | $36.95 | 54.50K |
| 2026-05-21 | GAYNOR RICHARD | Sell | 6.14K | — | — |
| 2026-05-21 | Cooke Shane | Buy | 6.14K | — | — |
| 2026-05-21 | Cooke Shane | Sell | 3.21K | $36.95 | 118.50K |
| 2026-05-21 | Cooke Shane | Sell | 6.14K | — | — |
| 2026-05-20 | Wright Christopher I | Buy | 11.54K | $36.98 | 426.68K |
| 2026-05-20 | Wright Christopher I | Buy | 5.41K | — | — |
| 2026-05-20 | Wilson Frank Anders | Buy | 11.54K | $36.98 | 426.68K |
| 2026-05-20 | Wilson Frank Anders | Buy | 5.41K | — | — |
| 2026-05-20 | snyderman nancy lynn MD | Buy | 11.54K | $36.98 | 426.68K |
| 2026-05-20 | snyderman nancy lynn MD | Buy | 5.41K | — | — |
| 2026-05-20 | MCKEON BRIAN P | Buy | 11.54K | $36.98 | 426.68K |
| 2026-05-20 | MCKEON BRIAN P | Buy | 5.41K | — | — |
| 2026-05-20 | Lurker Nancy | Buy | 11.54K | $36.98 | 426.68K |
| 2026-05-20 | Lurker Nancy | Buy | 5.41K | — | — |
| 2026-05-20 | LAURENCIN CATO T | Buy | 11.54K | $36.98 | 426.68K |
| 2026-05-20 | LAURENCIN CATO T | Buy | 5.41K | — | — |
| 2026-05-20 | GAYNOR RICHARD | Buy | 11.54K | $36.98 | 426.68K |
| 2026-05-20 | GAYNOR RICHARD | Buy | 5.41K | — | — |
| 2026-05-20 | Cooke Shane | Buy | 11.54K | $36.98 | 426.68K |
| 2026-05-20 | Cooke Shane | Buy | 5.41K | — | — |
| 2026-05-04 | Gaffin David Joseph | Sell | 2.03K | $33.20 | 67.53K |
| 2026-05-01 | Hopkinson Craig C. | Buy | 5.00K | $19.34 | 96.70K |
| 2026-05-01 | Hopkinson Craig C. | Sell | 9.00K | $33.40 | 300.56K |
| 2026-05-01 | Hopkinson Craig C. | Sell | 5.00K | $19.34 | 96.70K |
| 2026-04-11 | Lurker Nancy | Buy | 3.75K | — | — |
| 2026-04-11 | Lurker Nancy | Sell | 901 | $33.36 | 30.06K |
| 2026-04-11 | Lurker Nancy | Sell | 3.75K | — | — |
| 2026-04-06 | Gaffin David Joseph | Sell | 2.03K | $34.57 | 70.32K |
| 2026-04-01 | Hopkinson Craig C. | Buy | 5.00K | $19.34 | 96.70K |
| 2026-04-01 | Hopkinson Craig C. | Sell | 9.00K | $35.51 | 319.60K |
| 2026-04-01 | Hopkinson Craig C. | Sell | 5.00K | $19.34 | 96.70K |
| 2026-03-03 | Gaffin David Joseph | Sell | 2.03K | $29.76 | 60.53K |
| 2026-03-02 | Reed Joshua | Buy | 66.43K | $30.25 | 2.01M |
| 2026-03-02 | Reed Joshua | Buy | 30.85K | — | — |
| 2026-03-02 | POPS RICHARD F | Buy | 88.84K | — | — |
| 2026-03-02 | Parisi Samuel Joseph | Buy | 15.03K | $30.25 | 454.75K |
| 2026-03-02 | Parisi Samuel Joseph | Buy | 14.18K | — | — |
| 2026-03-02 | Parisi Samuel Joseph | Sell | 6.89K | $29.29 | 201.81K |
| 2026-03-02 | Nichols Christian Todd | Sell | 6.00K | $30.00 | 180.00K |
| 2026-03-02 | Nichols Christian Todd | Buy | 66.43K | $30.25 | 2.01M |
Latest filed quarter: Q2 2026.
Institutions holding: 437, holders +34 vs prior quarter. Ownership 108.21%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 29.24M | 921.33K | +3.25% | 1.53B |
| BAKER BROS. ADVISORS LP | 10.01M | 0 | 0.00% | 524.59M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 9.49M | -20.29K | -0.21% | 497.27M |
| STATE STREET CORP | 9.16M | -304.71K | -3.22% | 479.97M |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.52M | 87.63K | +1.18% | 393.75M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.74M | 2.07M | +44.44% | 353.00M |
| RENAISSANCE TECHNOLOGIES LLC | 6.46M | 300.50K | +4.88% | 338.52M |
| GEODE CAPITAL MANAGEMENT, LLC | 4.48M | 295.61K | +7.07% | 234.66M |
| DIMENSIONAL FUND ADVISORS LP | 4.19M | -327.50K | -7.24% | 219.79M |
| DEEP TRACK CAPITAL, LP | 4.00M | 409.68K | +11.41% | 209.58M |
| AMERICAN CENTURY COMPANIES INC | 3.95M | -2.12M | -34.88% | 207.18M |
| HOLOCENE ADVISORS, LP | 3.60M | 1.28M | +55.41% | 188.70M |
| COMMODORE CAPITAL LP | 3.00M | -1.20M | -28.57% | 157.19M |
| WELLINGTON MANAGEMENT GROUP LLP | 2.81M | -155.36K | -5.23% | 147.48M |
| PRIMECAP MANAGEMENT CO/CA/ | 2.53M | -11.31K | -0.45% | 132.49M |
| FIRST TRUST ADVISORS LP | 2.42M | -547.77K | -18.45% | 126.85M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.34M | 98.36K | +4.40% | 122.35M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 2.34M | 2.34M | New | 122.35M |
| NUVEEN, LLC | 2.32M | -136.37K | -5.54% | 121.78M |
| NORGES BANK | 2.16M | 2.16M | New | 113.01M |
| BVF INC/IL | 2.15M | 154.70K | +7.74% | 112.90M |
| GOLDMAN SACHS GROUP INC | 2.02M | 141.81K | +7.53% | 106.05M |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 1.94M | 1.33M | +217.69% | 101.54M |
| NORTHERN TRUST CORP | 1.83M | 134.54K | +7.93% | 95.97M |
| MORGAN STANLEY | 1.75M | 15.79K | +0.91% | 91.79M |
Consensus Buy from 29 analysts. Average price target $58.29, +28.1% versus the current price. Low $50.00. High $65.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $58.29 for Alkermes (ALKS), 28.1% above the current price of $45.51. Of 29 analysts covering the stock, 16 rate it Buy or Strong Buy, 10 Hold, and 3 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $50.00 |
|---|---|
| Average | $58.29 |
| High | $65.00 |
The average is 28.1% above the current price of $45.51.
Of 29 analysts, 16 rate Alkermes Buy or Strong Buy, 10 Hold, and 3 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS -0.54, revenue $1.82 billion. 2027, EPS $0.55, revenue $1.93 billion.
The Stocklytics Score for ALKS is 38 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$58.29 average, with a published range of $50.00 to $65.00.
The consensus is Buy from 29 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is -0.54. The average revenue estimate is $1.82 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Alkermes · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$7.63B
Market Cap
109.63
P/E
83.47
Forward P/E
38
Score